Safety Alert: VIT A / VIT C / VIT E / Copper / Zinc
Bausch + Lomb Recalls PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 Soft Gel
What does this mean?
Bausch + Lomb is asking consumers who currently have the PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 to return the product to Bausch + Lomb. Even if consumers are comfortable swallowing the soft gel, they are urged to return the product. Consumers who have this product in their home should call our customer service center for instructions on returning and reimbursement: 1-800-553-5340. Bausch + Lomb's customer service line is open to consumers 9am-5pm EST Monday through Friday.
Bausch + Lomb expects an AREDS 2 formulation in a smaller soft gel to be available to customers by later this year. Please follow up with your doctor or pharmacist if you have any questions about switching to a different supplement product or if you have questions about this recall.
Bausch + Lomb is conducting a voluntary recall of its PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 soft gels, only available in the United States. Bausch + Lomb has issued this recall based on a small number of reports of difficulty swallowing or a choking sensation when taking the soft gel. These reports were mainly from people age 70 and older.
The formulation of PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 is safe. Many consumers can comfortably swallow the supplement. However, Bausch + Lomb plans to redesign the soft gel into a smaller size so that consumes have a supplement which is easier to swallow.
The recalled PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 soft gels are packaged in 60 count bottles and labeled with the lot numbers 0923BK103, 0924BK103, 0924BK103A, 0925BK103A, 0926BK103A, 0927BK103A, 0928BK103A, 0929BK103A, or 0930BK103A.
The PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 is the only supplement affected in the recall. All other PreserVision and Ocuvite supplements, soft gels and tablets, remain on the market.
For more information, please visit:
Ask Us

